O2TODAY Announces Agreement to Develop Antimicrobial Face Masks with SINTX Technologies, Inc. to Help Prevent Spread of COVID...
August 04 2020 - 9:00AM
Business Wire
O2TODAY (www.O2TODAY.com), an original equipment manufacturer
(OEM) company who develops and commercializes face masks for
medical and non-medical applications, today announced that it has
entered into a joint development agreement with SINTX Technologies,
Inc. (NASDAQ: SINT) (“SINTX”) (www.sintx.com). The goal of this
agreement is to develop a safe and effective consumer face mask
with broad-spectrum antibacterial and antiviral activity, based on
incorporating SINTX’s unique silicon nitride powder into the mask
filter and fabric. The successful development of such a product may
help prevent the spread of respiratory diseases by catching and
inactivating SARS-CoV-2 and other viruses and bacteria in the mask
itself before they can enter into the human body.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200804005378/en/
One of the mask styles O2TODAY and SINTX
plan to develop research upon. (Photo: O2 Design, Inc.)
O2TODAY and SINTX Technologies intend to capitalize on recent
and promising data demonstrating the potential of SINTX’s silicon
nitride powder to inactivate the SARS-CoV-2 virus that is
responsible for the global COVID-19 pandemic. The study showing
rapid inactivation of SARS-CoV-2 by SINTX’s silicon nitride is the
latest in a series of scientific papers showing similar activity of
silicon nitride against a variety of bacteria and viral strains.
O2TODAY and SINTX plan to jointly fund collaborative research and
product development activities in Salt Lake City, Utah, with the
input of external laboratories as well. Upon the joint development
of an antimicrobial mask, the companies will enter a
commercialization agreement under which O2TODAY will be the
exclusive global distributor for face masks & replacement
filters containing SINTX’s silicon nitride.
“We were attracted to the scientific evidence that SINTX has
produced, attesting to the antimicrobial properties of silicon
nitride, the underlying mechanisms of antimicrobial action, and the
known safety of SINTX’s silicon nitride as an FDA-cleared spinal
implant,” said Bruce Lorange, CEO of O2TODAY. “The antibacterial
attributes of silicon nitride have been reproduced by
investigations done independently of SINTX, and that adds to the
credibility of SINTX’s findings. Our initial focus will create
products for the general public, with specific medical products
following soon after.
“With the outbreak of COVID-19, cloth masks and other face
coverings have been widely adopted in response to a lack of supply
of face masks with filters and certifications attesting to their
effectiveness against viruses,” said Lorange. “By increasing the
manufacture of surgical and respirator style masks with premium
US-sourced advanced ceramic materials, we aim to make effective
masks more readily available within the US to help reduce the
spread of virus transmission, and other airborne threats. The
collaboration with SINTX is intended to develop and bring to market
a much-needed product in the fight against COVID-19.”
Since 2015, O2TODAY has been an innovator in the design,
manufacturing, and marketing of protective face wear that reduces
exposure to airborne threats, from respiratory droplets and
pathogens to air pollution. The company’s products are distributed
through airport and travel retailers, direct-to-consumer, and
enterprise, and medical channels. The outbreak of COVID-19 has
boosted the market demand for respiratory and surgical masks with
overall shipments estimated to reach over 10 billion units by 2025
(*Source: Arizton Industry Report: Face Mask Market – Global
Outlook and Forecast 2020-2025). To control the supply chain from
raw material to finished goods, and to meet the demand for face
masks driven by COVID-19, O2TODAY has established a new production
facility in Salt Lake City, close to SINTX’s manufacturing plant,
to produce a range of products including surgical and N95 health
care respirator masks as well as replacement filters for its line
of reusable face masks. With current equipment and machinery,
O2TODAY anticipates being able to produce up to 100,000 single-use
masks or filters daily beginning September 1, 2020, with the
ability to rapidly scale to meet growing demand.
“We are pleased to enter this joint development agreement with
O2TODAY, toward developing a differentiated mask technology,” said
Dr. Sonny Bal, CEO, and President of SINTX Technologies. “The
collaboration with O2TODAY is intended to directly apply our
material science expertise toward new product development, and
revenues - a very significant and exciting move for SINTX. We look
forward to sharing more information on the testing, productization,
and distribution of face masks incorporating SINTX’s silicon
nitride in the coming months.”
About O2TODAY
O2TODAY (www.O2TODAY.com) is a privately-held company with its
headquarters located in Salt Lake City, Utah. Even before the
COVID-19 pandemic, O2TODAY designed and manufactured its
proprietary face mask technology that helps reduce exposure to
health threats resulting from respiratory droplets, pathogens,
allergens, dust, wildfire haze, and other forms of PM 2.5
particulate pollution. As a member of 1% For The Planet, O2TODAY
supports organizations driving initiatives to combat air pollution,
the leading environmental health threat on the planet, and
promoting public health through education of the medical risks
resulting from harmful air quality.
For more information on O2TODAY or its products, please visit
www.O2TODAY.com.
About SINTX Technologies, Inc.
SINTX Technologies is an OEM ceramics company that develops and
commercializes silicon nitride for medical and non-medical
applications. The core strength of SINTX Technologies is the
manufacturing, research, and development of silicon nitride
ceramics for external partners. The Company presently manufactures
silicon nitride powders and components in its FDA registered and
ISO 13485:2016 certified manufacturing facility.
For more information on SINTX Technologies or its silicon
nitride material platform, please visit www.sintx.com.
Forward-Looking Statements
SINTX Technologies: This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995 (PSLRA) that are subject to a number of risks
and uncertainties. Risks and uncertainties that may cause such
differences include, among other things, SINTX’s ability to
complete its obligations under the agreement; the collaboration
with O2TODAY may not result in the development of any products;
that SINTX has not as yet developed any products with antiviral
properties which incorporate the use of silicon nitride; products
developed under the joint development agreement may not be
effective against the SARS-CoV-2 virus; incorporation of silicon
nitride into personal protective equipment may not be safe or
effective; volatility in the price of SINTX’s common stock; the
uncertainties inherent in new product development, including the
cost and time required to commercialize such product(s); market
acceptance of our products once commercialized; SINTX’s ability to
raise additional funding and other competitive developments.
Readers are cautioned not to place undue reliance on the
forward-looking statements, which speak only as of the date on
which they are made and reflect management’s current estimates,
projections, expectations and beliefs. There can be no assurance
that any of the anticipated results will occur on a timely basis or
at all due to certain risks and uncertainties, a discussion of
which can be found in SINTX’s Risk Factors disclosure in its Annual
Report on Form 10-K, filed with the Securities and Exchange
Commission (SEC) on March 26, 2020, and in SINTX’s other filings
with the SEC. SINTX disclaims any obligation to update any
forward-looking statements. SINTX undertakes no obligation to
publicly revise or update the forward-looking statements to reflect
events or circumstances that arise after the date of this
report.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200804005378/en/
Business Inquiries for SINTX: SINTX Technologies
801.839.3502 IR@sintx.com
Media Inquiries for SINTX: Amanda Barry Associate
Director, Content and PR The Summit Group +1 509.554.8409
abarry@summitslc.com
Business Inquiries for O2TODAY: O2TODAY
info@o2today.com
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Mar 2024 to Apr 2024
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Apr 2023 to Apr 2024